The latest drugs on the FDA's radar.
Waldron
Theresa
T
waldron0606@behavioral.net
D000661:Amphetamine; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D000697:Central Nervous System Stimulants; D000075202:Contraindications; D017277:Drug Approval; D006801:Humans; D008774:Methylphenidate; D014481:United States; D014486:United States Food and Drug Administration
D000697:Central Nervous System Stimulants; D008774:Methylphenidate; D000661:Amphetamine